Attitudes Towards Buprenorphine and Methadone

Opioids Clinical Trial

— Att-1  

Official title:

Attitudes of Patients With Opioid-Substitution and Their Therapists Towards and Buprenorphine and Methadone

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00911846
• Other study ID #: E-10/2009
• Status: Recruiting
• Phase: N/A
• First received: May 28, 2009
• Last updated: May 28, 2009
• Start date: May 2009
• Est. completion date: June 2010

Study information

• Verified date: May 2009
• Source: Psychiatric University Hospital, Zurich
• Contact: Ria Leisinger, MD
• Phone: 0041 44 384 27 87
• Email: ria.leisinger[@]puk.zh.ch
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

Main intention of this study is to find out whether there is a difference between the attitudes towards opioid- substitution of opioid dependent patients under substitution with methadone, buprenorphine or without substitution and their therapists

Description:

Attitudes of patients and therapists can influence therapy success in both directions. Not much is known about patients' and their therapists' attitudes towards substitution medication. Our hypothesis is that the attitude towards buprenorphine is more positive than towards methadone even in patients taking methadone. Better knowledge about the influence of attitudes on treatment success could facilitate to adapt therapy to the patients' needs.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 180
• Est. completion date: June 2010
• Est. primary completion date: September 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Age between 18 and 65 years

• Opioid-dependent with substitution with buprenorphine,

• methadone or without substitution

• Sufficient knowledge of German language

Exclusion Criteria:

• Inability to give informed consent

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Addictive
• Opioids

Intervention

Other:
• interview
interview using questionnaires

Locations

Country	Name	City	State
Switzerland	Psychiatric University Hospital	Zurich	Kanton Zurich

Sponsors (1)

Lead Sponsor	Collaborator
Psychiatric University Hospital, Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Attitude toward buprenorphine compared over the four groups		one time of measurement	No
Secondary	Treatment success; Treatment conditions; Consumption of substances		one point of measurement	No